Wird geladen...
Pharmacological management of COVID-19 in type 2 diabetes
Evidence suggests that diabetes is one the most relevant comorbidity in affecting the prognosis of COVID-19. Albeit there are no specific trials nor subgroup analysis showing the effect of COVID-19 therapies in patients with diabetes, selected features of this disease and the side effects associated...
Gespeichert in:
| Veröffentlicht in: | J Diabetes Complications |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier Inc.
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8052602/ https://ncbi.nlm.nih.gov/pubmed/33896714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2021.107927 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|